Leptin receptor Q223R polymorphism in Egyptian female patients with breast cancer

Aim of the study: Breast cancer is the most common cause of death in women. Obesity has been associated with increased risk of breast cancer in post-menopausal women. It induces chronic inflammation, which increases local and systemic levels of cytokines and adipokines such as leptin. Leptin (LEP)...

Full description

Saved in:
Bibliographic Details
Main Authors: Mona Abo-Bakr El-Hussiny, Mohmed Ali Atwa, Waleed Elnahas Rashad, Dalia A. Shaheen, Nora Marzouk Elkady
Format: Article
Language:English
Published: Termedia Publishing House 2017-03-01
Series:Contemporary Oncology
Subjects:
Online Access:https://www.termedia.pl/Leptin-receptor-Q223R-polymorphism-in-Egyptian-female-patients-with-breast-cancer,3,29660,1,1.html
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850178760737816576
author Mona Abo-Bakr El-Hussiny
Mohmed Ali Atwa
Waleed Elnahas Rashad
Dalia A. Shaheen
Nora Marzouk Elkady
author_facet Mona Abo-Bakr El-Hussiny
Mohmed Ali Atwa
Waleed Elnahas Rashad
Dalia A. Shaheen
Nora Marzouk Elkady
author_sort Mona Abo-Bakr El-Hussiny
collection DOAJ
description Aim of the study: Breast cancer is the most common cause of death in women. Obesity has been associated with increased risk of breast cancer in post-menopausal women. It induces chronic inflammation, which increases local and systemic levels of cytokines and adipokines such as leptin. Leptin (LEP) and leptin receptor (LEPR) genes have several polymorphisms in humans. This study aims to assess the association between blood levels of leptin and LEPR Q223R gene polymorphism in patients of cancer breast. Material and methods : The current study was carried on 48 female breast cancer patients and 48 heathy female subjects. Carcinoembryonic antigen (CEA), cancer antibody CA15-3, and leptin hormone were determined. Single nucleotide polymorphism of LEPR Q223R was assessed by PCR/RFLP. Statistical analysis used: The statistical analysis of data was done by using SPSS version 20. Results : There were significant increases in the concentrations of CEA (p = 0.004), CA15-3 (p < 0.001), and leptin hormone (p < 0.001) in BC patients in relation to the respective concentrations in control subjects. CEA and CA 15-3 showed significant differences between various BC stages. As regard to LEPR Q223R gene polymorphism, AA genotype showed significantly higher frequency in BC patients when compared to their respective controls, with higher risk to develop BC. Conclusions : Leptin hormone shows significantly higher concentrations in BC patients. As regard to LEPR Q223R gene polymorphism, AA genotype showed significantly higher frequency in BC patients.
format Article
id doaj-art-89a4ccc9e61044f2b177fd809e04267f
institution OA Journals
issn 1428-2526
1897-4309
language English
publishDate 2017-03-01
publisher Termedia Publishing House
record_format Article
series Contemporary Oncology
spelling doaj-art-89a4ccc9e61044f2b177fd809e04267f2025-08-20T02:18:39ZengTermedia Publishing HouseContemporary Oncology1428-25261897-43092017-03-01211424710.5114/wo.2017.6665529660Leptin receptor Q223R polymorphism in Egyptian female patients with breast cancerMona Abo-Bakr El-HussinyMohmed Ali AtwaWaleed Elnahas RashadDalia A. ShaheenNora Marzouk ElkadyAim of the study: Breast cancer is the most common cause of death in women. Obesity has been associated with increased risk of breast cancer in post-menopausal women. It induces chronic inflammation, which increases local and systemic levels of cytokines and adipokines such as leptin. Leptin (LEP) and leptin receptor (LEPR) genes have several polymorphisms in humans. This study aims to assess the association between blood levels of leptin and LEPR Q223R gene polymorphism in patients of cancer breast. Material and methods : The current study was carried on 48 female breast cancer patients and 48 heathy female subjects. Carcinoembryonic antigen (CEA), cancer antibody CA15-3, and leptin hormone were determined. Single nucleotide polymorphism of LEPR Q223R was assessed by PCR/RFLP. Statistical analysis used: The statistical analysis of data was done by using SPSS version 20. Results : There were significant increases in the concentrations of CEA (p = 0.004), CA15-3 (p < 0.001), and leptin hormone (p < 0.001) in BC patients in relation to the respective concentrations in control subjects. CEA and CA 15-3 showed significant differences between various BC stages. As regard to LEPR Q223R gene polymorphism, AA genotype showed significantly higher frequency in BC patients when compared to their respective controls, with higher risk to develop BC. Conclusions : Leptin hormone shows significantly higher concentrations in BC patients. As regard to LEPR Q223R gene polymorphism, AA genotype showed significantly higher frequency in BC patients.https://www.termedia.pl/Leptin-receptor-Q223R-polymorphism-in-Egyptian-female-patients-with-breast-cancer,3,29660,1,1.htmlleptin leptin receptor LEPR Q223R gene polymorphism breast cancer
spellingShingle Mona Abo-Bakr El-Hussiny
Mohmed Ali Atwa
Waleed Elnahas Rashad
Dalia A. Shaheen
Nora Marzouk Elkady
Leptin receptor Q223R polymorphism in Egyptian female patients with breast cancer
Contemporary Oncology
leptin
leptin receptor
LEPR Q223R gene polymorphism
breast cancer
title Leptin receptor Q223R polymorphism in Egyptian female patients with breast cancer
title_full Leptin receptor Q223R polymorphism in Egyptian female patients with breast cancer
title_fullStr Leptin receptor Q223R polymorphism in Egyptian female patients with breast cancer
title_full_unstemmed Leptin receptor Q223R polymorphism in Egyptian female patients with breast cancer
title_short Leptin receptor Q223R polymorphism in Egyptian female patients with breast cancer
title_sort leptin receptor q223r polymorphism in egyptian female patients with breast cancer
topic leptin
leptin receptor
LEPR Q223R gene polymorphism
breast cancer
url https://www.termedia.pl/Leptin-receptor-Q223R-polymorphism-in-Egyptian-female-patients-with-breast-cancer,3,29660,1,1.html
work_keys_str_mv AT monaabobakrelhussiny leptinreceptorq223rpolymorphisminegyptianfemalepatientswithbreastcancer
AT mohmedaliatwa leptinreceptorq223rpolymorphisminegyptianfemalepatientswithbreastcancer
AT waleedelnahasrashad leptinreceptorq223rpolymorphisminegyptianfemalepatientswithbreastcancer
AT daliaashaheen leptinreceptorq223rpolymorphisminegyptianfemalepatientswithbreastcancer
AT noramarzoukelkady leptinreceptorq223rpolymorphisminegyptianfemalepatientswithbreastcancer